Key statistics
On Friday, VolitionRX Ltd (VNRX:ASQ) closed at 0.246, 11.82% above the 52 week low of 0.22 set on Dec 29, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.2575 |
|---|---|
| High | 0.2575 |
| Low | 0.24 |
| Bid | 0.246 |
| Offer | 0.26 |
| Previous close | 0.247 |
| Average volume | 2.03m |
|---|---|
| Shares outstanding | 122.80m |
| Free float | 103.07m |
| P/E (TTM) | -- |
| Market cap | 30.33m USD |
| EPS (TTM) | -0.229 USD |
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
More ▼
- Volition Sponsors Symposium at 15th Conference of the European Hidradenitis Suppurativa Foundation
- Volition Announces Data to Support Use of Nu.Q® NETs in New Indication
- Volition Continues to Extend Access to Nu.Q® Vet Cancer Test
- Volition Sponsors Symposium at Veterinary Meeting and Expo
- VolitionRx Secures $2.0 Million in Funding
- VolitionRx Announces Breakthrough Clinical Data for Nu.Q® Vet Cancer Test in Cats
- Volition Issues Business Review 2025
- Volition Solves Liquid Biopsy's "Needle in a Haystack" Problem; Achieves 180-fold (18,000%) Enrichment
- Volition Announces Two Abstracts were Presented at the North America Conference on Lung Cancer
- VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in France's Real-World Evaluation of Early Detection of Sepsis
More ▼
